R21 CA117070/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2009	1
2010	1
2011	1
2025	0

Page 1

Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors.

Gloghini A, Buglio D, Khaskhely NM, Georgakis G, Orlowski RZ, Neelapu SS, Carbone A, Younes A. Gloghini A, et al. Br J Haematol. 2009 Nov;147(4):515-25. doi: 10.1111/j.1365-2141.2009.07887.x. Epub 2009 Sep 22. Br J Haematol. 2009. PMID: 19775297 Free PMC article.

The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.

Buglio D, Mamidipudi V, Khaskhely NM, Brady H, Heise C, Besterman J, Martell RE, MacBeth K, Younes A. Buglio D, et al. Br J Haematol. 2010 Nov;151(4):387-96. doi: 10.1111/j.1365-2141.2010.08342.x. Epub 2010 Sep 29. Br J Haematol. 2010. PMID: 20880107 Free PMC article.

HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma.

Buglio D, Khaskhely NM, Voo KS, Martinez-Valdez H, Liu YJ, Younes A. Buglio D, et al. Blood. 2011 Mar 10;117(10):2910-7. doi: 10.1182/blood-2010-08-303701. Epub 2011 Jan 14. Blood. 2011. PMID: 21239696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year